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Recent World Health Organization (WHO)/United Nations Children’s Fund 
estimates suggest that the number of 
children with iron-deﬁ ciency  anaemia 
(IDA) is greater than 750 million [1]. 
Iron deﬁ ciency is the most common 
preventable nutritional problem 
despite continued global goals for its 
control. Historically, the problem of 
IDA in children largely disappeared in 
North America when foods fortiﬁ ed 
with iron and other micronutrients 
became available for children. In 
this group, the prevalence of IDA 
has fallen from 21% in 1974 to 13% 
in 1994 [2]. Although pockets of 
infants and children remain at risk, 
generally, the eradication of iron 
deﬁ ciency in developed countries is 
recognized as a successful public health 
accomplishment. This solution has not 
worked in developing countries where 
commercially purchased fortiﬁ ed foods 
are not available or are not used.
In the developing world, there are 
three major approaches available 
to address iron deﬁ ciency: dietary 
diversiﬁ cation so as to include foods 
rich in absorbable iron, fortiﬁ cation of 
staple food items (such as wheat ﬂ our), 
and the provision of iron supplements. 
When dietary or fortiﬁ cation strategies 
are not logistically or economically 
feasible, supplementation of individuals 
and groups at risk is an alternative 
strategy. For the past 150 years or more, 
oral ferrous sulphate syrups have been 
the primary strategy to control IDA 
in infants and young children [3]. 
However, adherence to the syrups is 
often limited owing to a combination 
of their unpleasant metallic aftertaste, 
the dark stain they leave on the child’s 
teeth, and abdominal discomfort [4]. 
Thus, despite the ongoing work of 
the United Nations Standing Sub-
Committee on Nutrition and others to 
solve the problem of poor adherence 
in infants and young children, all 
interventions to date have been 
universally unsuccessful [1,5]. In this 
article, we describe our efforts, stage 
by stage, towards achieving the goal of 
controlling IDA. 
The Strategy
Our research group at the Hospital for 
Sick Children in Toronto conceived 
the strategy of “home fortiﬁ cation” 
with “Sprinkles”—single-dose 
sachets containing micronutrients 
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in a powdered form, which are easily 
sprinkled onto any foods prepared in 
the household. We hypothesized that 
this would be a successful method to 
deliver iron and other micronutrients 
to children at risk [6]. The idea of 
Sprinkles was formulated in 1996, when 
a group of consultants determined 
that the prevention of childhood IDA 
was a United Nations Children’s Fund  
priority, yet available interventions 
(syrups and drops) were not effective 
[7].
In Sprinkles, the iron (ferrous 
fumarate) is encapsulated within 
a thin lipid layer to prevent the 
iron from interacting with food. 
This means that there are minimal 
changes to the taste, color, or texture 
of the food upon adding Sprinkles. 
Other micronutrients including 
zinc, iodine, vitamins C, D, and 
A, and folic acid may be added to 
Sprinkles sachets. Any homemade 
food can be fortiﬁ ed with the single-
dose sachets, hence the term “home 
fortiﬁ cation”. Two formulations have 
been developed, a nutritional anaemia 
formulation (Table 1) and a complete 
micronutrient formulation (Table 2). 
Clinical Trials
Efﬁ cacy. To investigate the 
bioavailability of the iron in Sprinkles, 
we used a dual stable isotope method 
and showed that anaemic infants 
absorbed iron from Sprinkles about 
twice as efﬁ ciently as nonanaemic 
infants when delivered in a maize-
based diet in West Africa. The study 
was conducted in collaboration with 
the Kintampo Health Research Centre 
of the Ministry of Health in Accra, 
Ghana. The geometric mean iron 
absorption from two doses of iron 
(30 mg and 45 mg of elemental iron 
per sachet) was 8.3% (range, 2.9%–
17.8%) in infants with anaemia and 
4.5% (range, 1.1%–10.6%) in infants 
without anaemia [8]. Comparing 
these absorption values to the new 
American/Canadian Dietary Reference 
Intake standards for infants, we 
concluded that during infancy (i) iron 
absorption of Sprinkles from a maize-
based porridge met and surpassed 
needs for absorbed iron, and (ii) iron 
absorption is up-regulated in infants 
with IDA [9,10,11]. Based on these 
results, we estimated through computer 
simulations that a 12.5-mg iron dose 
(as recommended by the WHO) from 
Sprinkles should be adequate for use 
in large-scale distribution programs for 
the prevention and treatment of mild 
to moderate anaemia.
It has been suggested that zinc 
may compete with iron for the same 
receptor sites on intestinal mucosal 
cells in the proximal duodenum, 
thereby compromising the absorption 
of both minerals [12]. To address this 
important issue, we recently conducted 
a bioavailability study in rural Ghana 
using the same dual stable isotope 
method as previously used [8]. In 
order to determine the effect of two 
doses of zinc on the absorption of 
iron from Sprinkles (with 30 mg of 
elemental iron), 63  young children, 
12–24 months of age with varying 
haemoglobin levels were studied. We 
found that 10 mg of zinc (in the form 
of zinc gluconate) added to Sprinkles 
signiﬁ cantly reduced the absorption 
of iron, whereas a 5-mg dose had 
no effect. Thus, we concluded that 
adding 5 mg of zinc to the formulation 
of Sprinkles was appropriate 
(unpublished data). 
Over the past ﬁ ve years, we have 
completed seven community-based 
trials in four different countries 
[13,14,15,16,17,18,19]. The goal of 
these studies was to test the efﬁ cacy 
of Sprinkles in diverse settings. When 
we pooled data from two of our 
studies that compared Sprinkles to the 
reference standard, ferrous sulphate 
drops, we had a total of 518 anaemic 
infants (haemoglobin < 100 g/l) who 
were given one of two ferrous sulphate 
doses (15 mg or 40 mg of elemental 
iron as ferrous sulphate) and 318 
similar infants who received one of 
four doses of iron from Sprinkles 
(12.5 mg, 20 mg, 30 mg, or 80 mg of 
elemental iron as microencapsulated 
ferrous fumarate) [13,18]. This gave 
us greater than 97% power (α = 0.05) 
to detect whether the mean difference 
in the end-of-study haemoglobin 
concentrations between ferrous 
sulphate and Sprinkles regimens was 
within ± 5 g/l (a range of equivalence). 
Using a random effects model (for 
study and dose) that adjusted for 
baseline haemoglobin, we found 
no signiﬁ cant difference between 
Sprinkles and drops. 
We further examined this through 
quantile-quantile plots of haemoglobin 
concentrations at the end of the studies 
for Sprinkles and ferrous sulphate 
drops (Figure 1). The overlaid plots 
of haemoglobin concentrations of the 
Sprinkles and drops groups show that 
these two distributions overlap at all 
quantiles. These plots clearly indicate 
that the haemoglobin response to 
the two different forms of iron was 
equivalent. Thus, we have concluded 
that Sprinkles are as efﬁ cacious as the 
current reference standard for the 
treatment of anaemia. Overall, 55%–
90% of the anaemic infants who were 
provided with Sprinkles were cured. 
Acceptability. During our studies 
we also asked about the caregivers’ 
perception of their infants’ responses 
to Sprinkles as compared to drops, the 
Sprinkles’ impact on the food to which 
they were added (change in taste, color, 
or consistency), the use of sachets as 
a delivery vehicle, and the perceived 
side effects of Sprinkles [13,18,19]. 
Invariably, the response to Sprinkles 
has been positive. No appreciable 
change in the food with Sprinkles has 
been reported, no one reported stains 
Table 1. Daily Dose and Derivation of Sprinkles Nutritional Anaemia Formulation for 
Home Fortifi cation of Complementary Foods 
Nutrient
Infants 6–11 Months Infants 12–24 Months Infants 6–24 Months
WHOa IOM DRIb WHOa IOM DRIb Sprinkles
Vitamin A, µg/d as retinol 
activity equivalents
 400  500c  400  300  300
Vitamin C, mg/d  30  50c  30  15  30
Folic acid, µg/d  80  80c  160  150  160
Iron, mg/dd  9.3  11  5.8  7  12.5
Zinc, mg/de  4.1  3  4.1  3  5
Data for infants and young children,  6–24 months of age.
a Recommended nutrient intake as determined by the WHO [10]. 
b Recommended dietary allowances as determined by the Institute of Medicine [9]. 
c Based on DRI “Adequate Intake” estimates.
d Assuming medium bioavailability (10%).
e Assuming moderate bioavailability (30%).
DRI, Dietary Reference Intake.
DOI: 10.1371/journal.pmed.0020001.t001
PLoS Medicine  |  www.plosmedicine.org 0026
on the infants’ teeth, and Sprinkles 
were reported to be easy to use. The 
only consistently reported side effect 
was a darkening of the infant’s stool, 
which is expected since most of the 
iron is excreted in stool. In a recently 
conducted study in Bangladesh, using 
a four-point measurement scale, 60% 
of the mothers “extremely liked”, 
30% “liked”, and the remaining 
10% “somewhat liked” the Sprinkles 
intervention; no one disliked Sprinkles. 
Major reasons cited for liking Sprinkles 
included ease in mixing Sprinkles 
with complementary (i.e., weaning) 
foods and that their use promoted 
the appropriate introduction of 
complementary foods, since Sprinkles 
could be used only if complementary 
foods were used [19]. 
Ensuring a Sustainable Supply
As the results of the ﬁ rst studies 
showing the efﬁ cacy of Sprinkles 
became available, the need for a 
reliable high-quality supply became 
apparent. In 2000, the H. J. Heinz 
Company of Pittsburgh, Pennsylvania, 
United States, expressed an interest in 
the Sprinkles program as a component 
of their corporate social responsibility 
program. Since 2001, the H. J. Heinz 
Company has provided support 
and expertise in the evaluation of 
consumer needs and a supply of 
Sprinkles for research, while the 
H. J. Heinz Company Foundation 
has provided ﬁ nancial support for 
research activities. Through a formal 
process of technology transfer, local 
overseas Sprinkles production has 
been encouraged. Currently, an 
independently licensed copacker is 
supporting local production for a 
national program in Guyana, and plans 
are in place for technology transfer to 
Bangladesh and Pakistan.
Scaling Up for Countrywide 
Distribution
The ﬁ nal stage, the scale-up process, 
is by far the most challenging. First, 
this process involves dialogue with 
the Ministries of Health, scientiﬁ c 
community, civil society, and other 
private partners. Second, it is 
important to identify sustainable 
methods of distribution that are 
able to reach and provide Sprinkles 
to the most vulnerable populations 
in the developing world. From our 
experience in Mongolia, we have 
determined that it is feasible to 
distribute Sprinkles in partnership 
with a non-governmental organization 
called World Vision. Sprinkles sachets 
distributed in Mongolia over a two-
year period included both iron and 
vitamin D. Sprinkles have been 
successfully distributed by World 
Vision ﬁ eld staff to over 15,000 
children in seven districts. Coverage 
has been over 80%, at a cost of about 
US$0.03 per sachet. In the project 
area, the prevalence of anaemia 
(haemoglobin < 115 g/l) and rickets 
decreased from 42% to 24% and 48% 
to 33%, respectively [20]. 
Notwithstanding these positive 
results on anaemia control, without 
committed, long-term ﬁ nancial 
input from national governments, 
international agencies, or non-
governmental organizations, 
sustainability is not guaranteed. Clearly, 
sustainability over the long term can 
most likely be achieved if a program 
becomes self-ﬁ nancing. This may be 
achieved through public- and private-
sector partnerships that use effective 
social marketing models or possibly 
through programs which include 
microcredit in order to reach poorer 
population groups. 
When strategizing how to scale up 
Sprinkles from small-scale research 
projects to large-scale programs, we 
quickly realized that our research 
group did not have the necessary 
funding, experience, or personnel 
needed to inﬂ uence health policy, 
develop a social marketing strategy, 
or maintain a distribution network 
at a countrywide  level. We have thus 
partnered with organizations that 
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Table 2. Daily Dose and Derivation of Sprinkles Complete Micronutrient Formulation for Home Fortifi cation of Complementary Foods 
Nutrient Infants 6–11 Months Infants 12–24 Months Infants 6–24 Months
WHOa IOM DRIb WHOa IOM DRIb
Lutter and 
Deweyc
Upper Limitb Sprinkles
Vitamin A, µg/d as retinol activity 
equivalents
 400  500d 400 300 250 600 300
Vitamin C, mg/d  30  50d 30 15 70–140 400 30
Vitamin D, µg/d  5  5d 5 5 1–2 25–50 5
Vitamin E, mg/d as α-tocopherol  NA  5d  NA 6  NA 200 6
Vitamin B1, mg/d  0.3  0.3d 0.5 0.5 0.18  NA 0.5
Vitamin B2, mg/d  0.4  0.4d  0.5 0.5 0.18  NA 0.5
Vitamin B6, mg/d  0.3  0.3d  0.5 0.5 0.22 30 0.5
Vitamin B12, µg/d  0.5  0.5d  0.9 0.9 0.26  NA 0.9
Folic acid, µg/d  80  80d  160 150 41.5 300 160
Niacin, mg/d  1.5  4d  6 6 3.3 10 6
Iron, mg/de  9.3  11  5.8 7 7–11 40 12.5
Zinc mg/df  4.1  3  4.1 3 4–5 5–7 5
Copper, mg/d  NA  0.22d  NA 0.34 0.2–0.4 1 0.3
Iodine, µg/d  NA  130d  90 90 90 200 90
Data for infants and young children, 6–24 months of age.
a Recommended nutrient intake as determined by the WHO [10]. 
b Recommended dietary allowances as determined by the Institute of Medicine [9].
c Recommended nutrient composition of complementary foods (per 50 g of food as daily ration) is based on a total intake of one recommended nutrient intake dose for all children six to 23 months after accounting for the amounts already 
present in breast milk and complementary food [11]. 
d Based on DRI Adequate Intake estimates.
e Assuming medium bioavailability (10%).
f Assuming moderate bioavailability (30%).
DRI, Dietary Reference Intake.
DOI: 10.1371/journal.pmed.0020001.t002
PLoS Medicine  |  www.plosmedicine.org 0027
specialize in each of these areas to 
help achieve our goal of sustainable 
distribution. 
For example, the government of 
Pakistan is planning to distribute 
Sprinkles through their ongoing 
Lady Health Worker Program, which 
is the largest public-sector primary 
health-care program implemented 
by the Federal Ministry of Health. In 
Bangladesh, BRAC (formerly known 
as Bangladesh Rural Advancement 
Committee), the largest national 
non-governmental organization in 
the country, is planning to distribute 
Sprinkles through their ongoing 
Female Community Health Worker 
program (popularly known as Shastha 
Shebika). In both of these countries, 
Sprinkles would be produced locally 
through public–private partnerships 
via a technology transfer agreement. 
The cost per sachet of locally produced 
Sprinkles should range from US$0.010 
to US$0.015, depending on the 
volume of production, as compared to 
US$0.020 to US$0.025 if imported. 
Conclusion
Each stage in the evolution of the 
Sprinkles intervention has been 
evaluated in a controlled manner. 
We determined that the use of 
encapsulated iron did not appreciably 
change the taste or color of the food 
to which it was added, we showed 
that the haemoglobin response in 
anaemic infants was equivalent to 
the current standard of practice, and 
we documented the acceptability of 
Sprinkles among caregivers who used 
Sprinkles in their homes. Finally, 
through various partnerships, we have 
developed a successful model to scale 
up the intervention for countrywide 
use. Our challenge for the future is to 
demonstrate the cost-effectiveness of this 
new intervention and to advocate for the 
adoption of Sprinkles in the nutrition 
policy of developing countries. 
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Figure 1. Overlaid Quantile-Quantile Plots of Haemoglobin Concentrations at the End of Studies for 
Sprinkles and Ferrous Sulphate Drops 
The graph shows that the two distributions overlap at all quantiles, thus proving that 
there is an equivalent response to the two treatments for haemoglobin concentrations. 
Circles represent individuals who received iron drops; crosses represent individuals who 
received Sprinkles. 
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